Gapping down
In reaction to earnings/guidance:
- AZEK -5.9%, HIBB -5.7%, BNS -2.6%
Other news:
- MIRM -9.8% (to discontinue the OHANA study of volixibat in intrahepatic cholestasis of pregnancy due to enrollment feasibility)
- CS -3.3% (makes pillar 3 and regulatory disclosures for 3Q22)
- SI -2.9% (issues statement regarding exposure to BlockFi)
- USNA -2.5% (acquires Rise Bar and Oola)
- ENFN -2.4% (CFO to resign; reiterates Q4 guidance)
- SF -1.4% (reports October operating results)
- ICHR -1.2% (names new COO)
Analyst comments:
- ROKU -3.3% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)
- EVRG -1.2% (downgraded to Underperform from Outperform at Credit Suisse)
- DRI -0.9% (downgraded to Neutral from Outperform at Robert Baird)